Second-line pembrolizumab for advanced HCC: Meta-analysis of the phase III KEYNOTE-240 and KEYNOTE-394 studies
晚期肝细胞癌二线治疗:帕博利珠单抗:KEYNOTE-240 和 KEYNOTE-394 III 期研究的荟萃分析
期刊:Jhep Reports
影响因子:7.5
doi:10.1016/j.jhepr.2025.101350
Finn, Richard S; Gu, Kangsheng; Chen, Xi; Merle, Philippe; Lee, Kyung-Hun; Bouattour, Mohamed; Cao, Peiguo; Wang, Wei; Cheng, Ann-Lii; Zhu, Liangjun; Lim, Ho Yeong; Kudo, Masatoshi; Pan, Yueyin; Chang, Ting-Tsung; Edeline, Julien; Li, Wei; Yang, Ping; Li, Chen; Li, Jianfeng; Siegel, Abby B; Qin, Shukui